Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:APYX NASDAQ:BDMD NASDAQ:EDAP OTCMKTS:GTHP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPYXApyx Medical$1.99-1.5%$2.14$0.76▼$2.73$75.26M1.4378,275 shs17,889 shsBDMDBaird Medical Investment$2.45+5.2%$2.89$1.05▼$12.50$87.54M-0.98256,651 shs220,096 shsEDAPEDAP TMS$2.26+24.2%$1.51$1.21▼$3.77$84.51M-0.21133,753 shs330,994 shsGTHPGuided Therapeutics$0.28+3.5%$0.25$0.06▼$0.32$23.20M0.3218,038 shs3,245 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPYXApyx Medical0.00%-4.78%+13.71%+22.84%+49.62%BDMDBaird Medical Investment0.00%+6.52%+28.27%-44.44%+244,999,900.00%EDAPEDAP TMS0.00%+63.77%+73.39%+24.69%-37.57%GTHPGuided Therapeutics0.00%+6.31%+11.80%+99.64%+102.54%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAPYXApyx Medical1.8792 of 5 stars0.03.00.04.23.01.70.6BDMDBaird Medical InvestmentN/AN/AN/AN/AN/AN/AN/AN/AEDAPEDAP TMS2.9119 of 5 stars3.25.00.00.02.51.70.6GTHPGuided TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPYXApyx Medical 2.67Moderate BuyN/AN/ABDMDBaird Medical Investment 0.00N/AN/AN/AEDAPEDAP TMS 2.33Hold$8.50276.11% UpsideGTHPGuided Therapeutics 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPYXApyx Medical$48.10M1.56N/AN/A$0.38 per share5.24BDMDBaird Medical InvestmentN/AN/AN/AN/AN/AN/AEDAPEDAP TMS$69.18M1.22N/AN/A$1.18 per share1.92GTHPGuided Therapeutics$10K2,319.85N/AN/A($0.12) per share-2.33Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPYXApyx Medical-$23.46M-$0.45N/AN/AN/A-37.11%-158.22%-28.30%11/7/2025 (Estimated)BDMDBaird Medical InvestmentN/AN/A0.00∞N/AN/AN/AN/AN/AEDAPEDAP TMS-$20.58M-$0.61N/AN/AN/A-33.49%-56.85%-26.83%11/5/2025 (Estimated)GTHPGuided Therapeutics-$2.42M-$0.05N/A∞N/AN/AN/A-219.85%11/12/2025 (Estimated)Latest GTHP, BDMD, EDAP, and APYX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025GTHPGuided TherapeuticsN/A-$0.01N/A-$0.01N/A$0.12 million8/7/2025Q2 2025APYXApyx Medical-$0.0933-$0.09+$0.0033-$0.09$11.69 million$11.37 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAPYXApyx MedicalN/AN/AN/AN/AN/ABDMDBaird Medical InvestmentN/AN/AN/AN/AN/AEDAPEDAP TMSN/AN/AN/AN/AN/AGTHPGuided TherapeuticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPYXApyx Medical4.614.723.95BDMDBaird Medical InvestmentN/AN/AN/AEDAPEDAP TMS0.041.511.05GTHPGuided TherapeuticsN/A0.130.03Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPYXApyx Medical55.33%BDMDBaird Medical Investment19.78%EDAPEDAP TMS62.74%GTHPGuided Therapeutics9.69%Insider OwnershipCompanyInsider OwnershipAPYXApyx Medical15.20%BDMDBaird Medical Investment78.90%EDAPEDAP TMS0.23%GTHPGuided Therapeutics66.83%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPYXApyx Medical27037.82 million32.07 millionOptionableBDMDBaird Medical InvestmentN/A35.73 million7.54 millionN/AEDAPEDAP TMS23037.39 million37.31 millionOptionableGTHPGuided Therapeutics583.00 million27.53 millionNot OptionableGTHP, BDMD, EDAP, and APYX HeadlinesRecent News About These CompaniesGuided Therapeutics Receives $70,000 -- Its Second of Nine Payments Totaling $700,000 -- from New Chinese Distribution Partner that Provides Products for 2 Million Annual ...August 19, 2025 | finance.yahoo.comGuided Therapeutics Provides Update on Completion of US FDA Clinical TrialAugust 13, 2025 | finance.yahoo.comGuided Therapeutics Makes Initial Shipment to New Chinese Distribution Partner Hangzhou Dongye Medical Technology, Ltd. - MorningstarJuly 3, 2025 | morningstar.comMGuided Therapeutics Makes Initial Shipment to New Chinese Distribution Partner Hangzhou Dongye Medical Technology, Ltd.July 2, 2025 | finance.yahoo.comGuided Therapeutics (OTC:GTHP) Stock, Short Interest ReportJune 29, 2025 | benzinga.comGuided Therapeutics Stock (OTC:GTHP) Insider TradesJune 29, 2025 | benzinga.comGuided Therapeutics Receives $700,000 Purchase Order and Initial Payment from New Chinese DistributorJune 10, 2025 | finance.yahoo.comGuided Therapeutics Receives $100,000 from SMI’s Investment Partners to Continue Commercialization Process of LuViva in ChinaMay 27, 2025 | finance.yahoo.comHAYA Therapeutics Raises $65 Million in Series A Funding to Deliver Precision RNA-Guided Medicines for Chronic and Age-Related DiseasesMay 10, 2025 | morningstar.comMGuided Therapeutics Receives Order and Full Payment From Indonesia for 4 LuViva Systems and 1,200 DisposablesDecember 11, 2024 | accesswdun.comAGuided Therapeutics Announces Filing of Application for NMPA Approval to Market and Sell LuViva in ChinaOctober 22, 2024 | finance.yahoo.comThe GLP-1 telehealth boom, Senate investigation of MA plans, and the fall of a cancer startupOctober 17, 2024 | statnews.comSGuided therapeutics director buys shares worth $150,000October 4, 2024 | investing.comGuided Therapeutics Inc (GTHP)August 21, 2024 | investing.comWhy clinical trials for digital therapeutics are getting more rigorousJuly 19, 2024 | statnews.comSG1 Therapeutics, Inc. (NASDAQ:GTHX) Q1 2024 Earnings Call TranscriptMay 2, 2024 | msn.comLeading Cervical Cancer Doctors Support Approval of LuViva in China Based on Preliminary Review of Clinical Trial ResultsFebruary 20, 2024 | finance.yahoo.comLeading Cervical Cancer Doctors Support Approval of LuViva in China Based on Preliminary Review of Clinical Trial ResultsFebruary 20, 2024 | businesswire.comlaser guidedJanuary 18, 2024 | hackaday.comHGuided Therapeutics IncNovember 20, 2023 | thestreet.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeGTHP, BDMD, EDAP, and APYX Company DescriptionsApyx Medical NASDAQ:APYX$1.99 -0.03 (-1.49%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$1.98 -0.01 (-0.75%) As of 08/29/2025 04:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.Baird Medical Investment NASDAQ:BDMD$2.45 +0.12 (+5.15%) As of 08/29/2025 04:00 PM EasternBaird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.EDAP TMS NASDAQ:EDAP$2.26 +0.44 (+24.18%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$2.16 -0.10 (-4.42%) As of 08/29/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.Guided Therapeutics OTCMKTS:GTHP$0.28 +0.01 (+3.52%) As of 08/29/2025 03:59 PM EasternGuided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 08/25 - 08/29 Ollie’s Bargain Outlet: Buy it While It’s Still a Bargain Tencent Music Stock Outshines Spotify as China’s Music Giant With Shares Near Highs, Here's to Watch in Broadcom's Q3 Report Best Buy Marketplace: Potential Growth Catalyst or Risky Gimmick? DICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy? CrowdStrike at a Crossroads: AI Halo vs. Risks Snowflake’s Snowballing Business and Robust Stock Price Outlook Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
